100 U.S. Patients Treated in Clinical Trial of Baguera C Spinal Disc

Spineart USA achieved the milestone of 100 patients treated in the single-level U.S. Investigational Device Exemption (IDE) clinical trial of the BAGUERA® C cervical disc. BAGUERA C is an investigational device in the U.S. and is designed to reconstruct the cervical disc following discectomy for symptomatic cervical disc disease.

Spineart is...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us